Quisinostat 2HCl
| CAS No. | 875320-31-3 | Cat. No. | BCP20792 |
| Name | Quisinostat 2HCl | ||
| Synonyms | JNJ26481585; JNJ-26481585; JNJ 26481585; JNJ-26481585-AAC; JNJ26854165 2HCl; | ||
| Formula | C21H28Cl2N6O2 | M. Wt | 467.40 |
| Description | Potent, orally available second-generation pan-HDAC inhibitor (highest IC50 value 0.11 nM for HDAC1, and sub-nanomolar for HDAC2, HDAC4, HDAC10, and HDAC11 in vitro) with activity in human leukemia. JNJ-26481585 induces continuous acetylation of histone H3, activation of the caspase cascade, and upregulation of p21, resulting in apoptosis and cell cycle arrest in the myeloma cells at low nanomolar concentrations. JNJ26481585 also potently induced tubulin acetylation. | ||
| Pathways | Cell Cycle/DNA Damage Epigenetics | ||
| Targets | HDAC | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.